Literature DB >> 18034663

Dose-response effect of ellagic acid on circulatory antioxidants and lipids during alcohol-induced toxicity in experimental rats.

Nagarajan Devipriya1, Adluri Ram Sudheer, Venugopal P Menon.   

Abstract

Ellagic acid (EA) is a naturally occurring polyphenolic compound that exhibits antioxidative, anti-inflammatory, anti-hyperlipidaemic and anticarcinogenic activities in a wide range of assays both in vitro and in vivo. It occurs in various foods such as strawberries, grapes, walnuts, etc. The aim of this study was to assess the effect of ellagic acid on alcohol-induced changes in the circulatory antioxidative status, micronutrients and lipid levels in a dose-dependent fashion. Female albino Wistar rats weighing 150-170 g were used to assess the effects of EA against alcohol-induced damage. Three different concentrations of EA (30, 60 and 90 mg/kg body weight) were tested against 20% alcohol via intragastric administration. At the end of the experimental duration of 45 days, we evaluated endogenous antioxidants: both enzymatic (superoxide dismutase, catalase and glutathione peroxidase) and non-enzymatic (vitamin C and E, and reduced glutathione) status, micronutrients, viz. copper and zinc, and lipids: cholesterol, triglycerides, free fatty acids and phospholipids in the circulation. The body weight gain of both alcohol-fed rats and EA-treated rats were also inferred. EA significantly inhibits alcohol-induced toxicity by improving body weight, restoring antioxidant status, modulating micronutrients and attenuating the lipid levels in the circulation. The greatest inhibitory effect was observed with 60 mg/kg body weight of EA in all the biochemical assessments. The results support the hypothesis that EA at the concentration of 60 mg/kg body weight decreases the intensity of alcohol-induced toxicity and could be developed as a potential drug for alcohol abuse in the near future.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18034663     DOI: 10.1111/j.1472-8206.2007.00551.x

Source DB:  PubMed          Journal:  Fundam Clin Pharmacol        ISSN: 0767-3981            Impact factor:   2.748


  6 in total

1.  Gallic and ellagic acids: two natural immunomodulator compounds solve infection of macrophages by Leishmania major.

Authors:  Michel Muálem de Moraes Alves; Lucas Moreira Brito; Adriana Cunha Souza; Bárbara Cristina Silva Holanda Queiroz; Thaynara Parente de Carvalho; Joilson Ferreira Batista; Jéssica Sara de Sousa Macêdo Oliveira; Ivete Lopes de Mendonça; Silvéria Regina de Sousa Lira; Mariana Helena Chaves; Juan Carlos Ramos Gonçalves; Sabrina Maria Portela Carneiro; Daniel Dias Rufino Arcanjo; Fernando Aécio de Amorim Carvalho
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-06-22       Impact factor: 3.000

2.  Quantitative and fingerprint analyses of Chinese sweet tea plant ( Rubus suavissimus S. Lee).

Authors:  Guixin Chou; Shun-Jun Xu; Dong Liu; Gar Yee Koh; Jian Zhang; Zhijun Liu
Journal:  J Agric Food Chem       Date:  2009-02-11       Impact factor: 5.279

Review 3.  Ellagic acid in suppressing in vivo and in vitro oxidative stresses.

Authors:  Alam Zeb
Journal:  Mol Cell Biochem       Date:  2018-01-31       Impact factor: 3.396

4.  Hepatoprotective activities of picroliv, curcumin, and ellagic acid compared to silymarin on carbon-tetrachloride-induced liver toxicity in mice.

Authors:  C Girish; S C Pradhan
Journal:  J Pharmacol Pharmacother       Date:  2012-04

5.  Camu-Camu Fruit Extract Inhibits Oxidative Stress and Inflammatory Responses by Regulating NFAT and Nrf2 Signaling Pathways in High Glucose-Induced Human Keratinocytes.

Authors:  Nhung Quynh Do; Shengdao Zheng; Bom Park; Quynh T N Nguyen; Bo-Ram Choi; Minzhe Fang; Minseon Kim; Jeehaeng Jeong; Junhui Choi; Su-Jin Yang; Tae-Hoo Yi
Journal:  Molecules       Date:  2021-05-26       Impact factor: 4.411

6.  A comparative study for the evaluation of two doses of ellagic acid on hepatic drug metabolizing and antioxidant enzymes in the rat.

Authors:  Gurbet Celik; Aslı Semiz; Serdar Karakurt; Sevki Arslan; Orhan Adali; Alaattin Sen
Journal:  Biomed Res Int       Date:  2013-07-18       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.